Palatin Technologies, Inc. (PTN)
USD 0.75
(-9.64%)
USD 0.75
(-9.64%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 10.85 Million USD | -39.04% |
| 2023 | 17.8 Million USD | -10.09% |
| 2022 | 19.8 Million USD | 12.23% |
| 2021 | 17.64 Million USD | 261.52% |
| 2020 | 4.88 Million USD | 16.6% |
| 2019 | 4.18 Million USD | -65.27% |
| 2018 | 12.05 Million USD | -80.56% |
| 2017 | 61.99 Million USD | 116.49% |
| 2016 | 28.63 Million USD | 65.82% |
| 2015 | 17.26 Million USD | 523.41% |
| 2014 | 2.77 Million USD | 32.18% |
| 2013 | 2.09 Million USD | -40.96% |
| 2012 | 3.54 Million USD | 19.07% |
| 2011 | 2.98 Million USD | -2.92% |
| 2010 | 3.07 Million USD | -68.94% |
| 2009 | 9.88 Million USD | -21.37% |
| 2008 | 12.57 Million USD | -48.15% |
| 2007 | 24.24 Million USD | 11.5% |
| 2006 | 21.74 Million USD | -16.17% |
| 2005 | 25.94 Million USD | 419.61% |
| 2004 | 4.99 Million USD | 22.83% |
| 2003 | 4.06 Million USD | 10.71% |
| 2002 | 3.67 Million USD | 57.67% |
| 2001 | 2.32 Million USD | 17.59% |
| 2000 | 1.98 Million USD | -54.99% |
| 1999 | 4.4 Million USD | 41.94% |
| 1998 | 3.1 Million USD | -27.91% |
| 1997 | 4.3 Million USD | 2.31% |
| 1996 | 4.2 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 9.82 Million USD | -59.91% |
| 2024 Q2 | 24.51 Million USD | 51.93% |
| 2024 Q1 | 16.13 Million USD | 2.64% |
| 2024 Q4 | 10.85 Million USD | 10.44% |
| 2023 Q2 | 15.63 Million USD | -18.55% |
| 2023 Q3 | 16.01 Million USD | 2.45% |
| 2023 FY | 17.8 Million USD | -10.09% |
| 2023 Q1 | 19.19 Million USD | -3.08% |
| 2023 Q4 | 15.72 Million USD | -1.84% |
| 2022 Q1 | 16.76 Million USD | -4.99% |
| 2022 Q2 | 17.79 Million USD | 6.17% |
| 2022 Q3 | 15.73 Million USD | -11.61% |
| 2022 FY | 19.8 Million USD | 12.23% |
| 2022 Q4 | 19.8 Million USD | 25.88% |
| 2021 Q4 | 17.64 Million USD | -1.95% |
| 2021 Q1 | 24.18 Million USD | 395.46% |
| 2021 Q2 | 18.94 Million USD | -21.67% |
| 2021 FY | 17.64 Million USD | 261.52% |
| 2021 Q3 | 17.99 Million USD | -5.0% |
| 2020 Q4 | 4.88 Million USD | 44.92% |
| 2020 Q1 | 1.85 Million USD | -55.8% |
| 2020 FY | 4.88 Million USD | 16.6% |
| 2020 Q3 | 3.36 Million USD | 142.57% |
| 2020 Q2 | 1.38 Million USD | -24.96% |
| 2019 Q4 | 4.18 Million USD | -15.25% |
| 2019 Q3 | 4.93 Million USD | 9.07% |
| 2019 Q2 | 4.52 Million USD | -46.47% |
| 2019 Q1 | 8.45 Million USD | -29.8% |
| 2019 FY | 4.18 Million USD | -65.27% |
| 2018 FY | 12.05 Million USD | -80.56% |
| 2018 Q2 | 27.35 Million USD | -38.61% |
| 2018 Q1 | 44.56 Million USD | -28.12% |
| 2018 Q4 | 12.05 Million USD | -28.83% |
| 2018 Q3 | 16.93 Million USD | -38.1% |
| 2017 Q2 | 30.42 Million USD | -8.26% |
| 2017 FY | 61.99 Million USD | 116.49% |
| 2017 Q3 | 80.14 Million USD | 163.4% |
| 2017 Q1 | 33.16 Million USD | 15.81% |
| 2017 Q4 | 61.99 Million USD | -22.64% |
| 2016 Q4 | 28.63 Million USD | -3.29% |
| 2016 FY | 28.63 Million USD | 65.82% |
| 2016 Q1 | 29.44 Million USD | 70.53% |
| 2016 Q2 | 27.91 Million USD | -5.2% |
| 2016 Q3 | 29.61 Million USD | 6.06% |
| 2015 Q2 | 14.91 Million USD | 94.88% |
| 2015 FY | 17.26 Million USD | 523.41% |
| 2015 Q1 | 7.65 Million USD | 176.3% |
| 2015 Q3 | 15.04 Million USD | 0.86% |
| 2015 Q4 | 17.26 Million USD | 14.79% |
| 2014 Q3 | 3.38 Million USD | -2.98% |
| 2014 FY | 2.77 Million USD | 32.18% |
| 2014 Q2 | 3.49 Million USD | -17.28% |
| 2014 Q1 | 4.22 Million USD | 101.47% |
| 2014 Q4 | 2.77 Million USD | -18.25% |
| 2013 Q3 | 2.79 Million USD | 32.11% |
| 2013 Q4 | 2.09 Million USD | -24.88% |
| 2013 FY | 2.09 Million USD | -40.96% |
| 2013 Q1 | 1.7 Million USD | -51.91% |
| 2013 Q2 | 2.11 Million USD | 23.72% |
| 2012 Q2 | 2.33 Million USD | 29.85% |
| 2012 Q3 | 3.54 Million USD | 52.11% |
| 2012 Q4 | 3.54 Million USD | 0.14% |
| 2012 FY | 3.54 Million USD | 19.07% |
| 2012 Q1 | 1.79 Million USD | -39.8% |
| 2011 Q3 | 8.52 Million USD | 249.6% |
| 2011 Q4 | 2.98 Million USD | -65.04% |
| 2011 FY | 2.98 Million USD | -2.92% |
| 2011 Q1 | 3.3 Million USD | 7.63% |
| 2011 Q2 | 2.43 Million USD | -26.2% |
| 2010 FY | 3.07 Million USD | -68.94% |
| 2010 Q4 | 3.07 Million USD | 2.66% |
| 2010 Q3 | 2.99 Million USD | 22.28% |
| 2010 Q2 | 2.44 Million USD | -72.52% |
| 2010 Q1 | 8.9 Million USD | -9.95% |
| 2009 Q3 | 13.77 Million USD | -2.61% |
| 2009 FY | 9.88 Million USD | -21.37% |
| 2009 Q4 | 9.88 Million USD | -28.23% |
| 2009 Q2 | 14.14 Million USD | 22.11% |
| 2009 Q1 | 11.58 Million USD | -7.87% |
| 2008 Q4 | 12.57 Million USD | -7.84% |
| 2008 Q1 | 15.62 Million USD | -35.58% |
| 2008 FY | 12.57 Million USD | -48.15% |
| 2008 Q2 | 14.42 Million USD | -7.65% |
| 2008 Q3 | 13.64 Million USD | -5.44% |
| 2007 Q1 | 19.87 Million USD | -8.63% |
| 2007 FY | 24.24 Million USD | 11.5% |
| 2007 Q3 | 27.71 Million USD | 39.36% |
| 2007 Q4 | 24.24 Million USD | -12.5% |
| 2007 Q2 | 19.88 Million USD | 0.08% |
| 2006 Q3 | 25.19 Million USD | 4.94% |
| 2006 Q4 | 21.74 Million USD | -13.69% |
| 2006 FY | 21.74 Million USD | -16.17% |
| 2006 Q2 | 24 Million USD | -2.97% |
| 2006 Q1 | 24.74 Million USD | -4.61% |
| 2005 Q4 | 25.94 Million USD | 7.68% |
| 2005 Q3 | 24.09 Million USD | 10.73% |
| 2005 Q2 | 21.75 Million USD | 0.41% |
| 2005 Q1 | 21.66 Million USD | 334.02% |
| 2005 FY | 25.94 Million USD | 419.61% |
| 2004 FY | 4.99 Million USD | 22.83% |
| 2004 Q4 | 4.99 Million USD | 3.99% |
| 2004 Q3 | 4.8 Million USD | 71.99% |
| 2004 Q1 | 6.34 Million USD | 56.12% |
| 2004 Q2 | 2.79 Million USD | -56.01% |
| 2003 Q2 | 3.37 Million USD | -13.58% |
| 2003 Q1 | 3.9 Million USD | 6.43% |
| 2003 FY | 4.06 Million USD | 10.71% |
| 2003 Q3 | 5.06 Million USD | 50.1% |
| 2003 Q4 | 4.06 Million USD | -19.81% |
| 2002 Q2 | 2.61 Million USD | 17.91% |
| 2002 Q1 | 2.21 Million USD | -4.76% |
| 2002 Q3 | 2.63 Million USD | 0.95% |
| 2002 FY | 3.67 Million USD | 57.67% |
| 2002 Q4 | 3.67 Million USD | 39.08% |
| 2001 Q2 | 1.89 Million USD | 6.1% |
| 2001 Q4 | 2.32 Million USD | 33.13% |
| 2001 Q3 | 1.74 Million USD | -7.54% |
| 2001 FY | 2.32 Million USD | 17.59% |
| 2001 Q1 | 1.78 Million USD | -9.96% |
| 2000 Q1 | 2.7 Million USD | -38.64% |
| 2000 FY | 1.98 Million USD | -54.99% |
| 2000 Q2 | 2.5 Million USD | -7.41% |
| 2000 Q3 | 1.57 Million USD | -36.83% |
| 2000 Q4 | 1.98 Million USD | 25.39% |
| 1999 Q1 | 2.8 Million USD | -9.68% |
| 1999 FY | 4.4 Million USD | 41.94% |
| 1999 Q4 | 4.4 Million USD | 83.33% |
| 1999 Q3 | 2.4 Million USD | 4.35% |
| 1999 Q2 | 2.3 Million USD | -17.86% |
| 1998 Q3 | 3.1 Million USD | 3.33% |
| 1998 FY | 3.1 Million USD | -27.91% |
| 1998 Q1 | 3.6 Million USD | -14.29% |
| 1998 Q2 | 3 Million USD | -16.67% |
| 1998 Q4 | 3.1 Million USD | 0.0% |
| 1997 Q1 | 2.9 Million USD | -30.95% |
| 1997 Q2 | 2.6 Million USD | -10.34% |
| 1997 Q4 | 4.2 Million USD | 35.48% |
| 1997 Q3 | 3.1 Million USD | 19.23% |
| 1997 FY | 4.3 Million USD | 2.31% |
| 1996 FY | 4.2 Million USD | 0.0% |
| 1996 Q4 | 4.2 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 9.14 Million USD | -18.659% |
| Ampio Pharmaceuticals, Inc. | 2.37 Million USD | -356.808% |
| Armata Pharmaceuticals, Inc. | 142.02 Million USD | 92.358% |
| Actinium Pharmaceuticals, Inc. | 45.06 Million USD | 75.916% |
| Azitra, Inc. | 2.2 Million USD | -392.829% |
| Can-Fite BioPharma Ltd. | 3.74 Million USD | -189.743% |
| Chromocell Therapeutics Corporation | 6.54 Million USD | -65.936% |
| Calidi Biotherapeutics, Inc. | 18.25 Million USD | 40.54% |
| CEL-SCI Corporation | 17.31 Million USD | 37.31% |
| iBio, Inc. | 7.41 Million USD | -46.475% |
| Lineage Cell Therapeutics, Inc. | 38.99 Million USD | 72.167% |
| MAIA Biotechnology, Inc. | 7.08 Million USD | -53.1% |
| Matinas BioPharma Holdings, Inc. | 46.33 Million USD | 76.574% |
| Navidea Biopharmaceuticals, Inc. | 12.51 Million USD | 13.273% |
| NovaBay Pharmaceuticals, Inc. | 5.72 Million USD | -89.751% |
| NanoViricides, Inc. | 1.35 Million USD | -698.79% |
| Oragenics, Inc. | 1.79 Million USD | -503.597% |
| BiomX Inc. | 55.07 Million USD | 80.293% |
| BiomX Inc. | 55.07 Million USD | 80.293% |
| Protalix BioTherapeutics, Inc. | 50.86 Million USD | 78.662% |
| Scorpius Holdings, Inc. | 22.74 Million USD | 52.277% |